DocGo Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
DocGo Inc. (DCGO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-17
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- DocGo Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 5 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-17 | ||||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-11 | ||||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-10 | ||||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | 0.00% 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-07 | ||||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-08 | ||||
| 2023-12-31 | 0.00% 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-08 | ||||
| 2022-12-31 | 0.00% 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-08 | ||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-10 | ||||
| 2020-12-31 | 0.00% 10-K/A · filed 2021-11-24 | 0.00% 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |